• CRISPR-Cas9 Editing of LGMN Suppresses Breast Cancer Metasta

  2026-05-09

  This study demonstrates that co-delivery of Cas9 mRNA and guide RNAs targeting the LGMN gene significantly impairs breast cancer cell metastasis, both in vitro and in vivo. Key methodological advances include optimized in vitro transcription of gRNA and Cas9 mRNA, with implications for improved gene-editing approaches in cancer research.

• Prednisone in Bench Research: Protocols, Use Cases, and Trou

  2026-05-08

  Prednisone, a synthetic corticosteroid, is a cornerstone for immunosuppression and apoptosis assays in cellular and neurodegeneration research. This article delivers stepwise protocols, practical troubleshooting, and evidence-based workflow enhancements—translating both product documentation and recent metabolomics insights into actionable strategies for reproducible results.

• Methyl-β-cyclodextrin: Technical Use in Membrane Cholesterol

  2026-05-08

  Methyl-β-cyclodextrin facilitates selective extraction of cholesterol and lipids from cellular membranes, supporting research on membrane fluidity, lipid raft disruption, and cholesterol-dependent signaling. This reagent is not suitable for diagnostic or medical use and should be handled according to product-specific protocols to ensure reliability.

• Cinoxacin: Mechanism, Spectrum, and Pharmacokinetic Insights

  2026-05-07

  This article reviews the seminal study on Cinoxacin, emphasizing its unique mechanism as a quinolone antibiotic, its spectrum against Gram-negative bacteria, and its pharmacokinetics relevant to urinary tract infection research. The findings support Cinoxacin as a reference agent for laboratory studies on antimicrobial resistance and pharmacodynamic modeling.

• CHI3L1-IN-5: Precision NF-κB Pathway Inhibition for Neuroinf

  2026-05-07

  Explore the unique dual mechanism of CHI3L1-IN-5 (Compound Z17) as a highly specific NF-κB pathway inhibitor. This in-depth analysis reveals how its structure-activity optimization advances both mechanistic insight and real-world assay design in neurodegenerative disease research.

• Sumatriptan Succinate: Mechanisms & Anti-Inflammatory Eviden

  2026-05-06

  Sumatriptan Succinate, a selective 5-HT1 receptor agonist, is validated for migraine research and demonstrates anti-inflammatory properties in both cellular and animal models. Its precise receptor affinity, metabolism, and workflow parameters are well characterized, supporting robust serotonergic signaling research.

• GSK343 (SKU A3449): Optimizing EZH2 Inhibitor Workflows in C

  2026-05-06

  This article addresses core experimental challenges in cell-based epigenetic assays, highlighting how GSK343 (SKU A3449) enables reproducible, data-driven advances in EZH2 research. Drawing on recent literature and scenario-based Q&A, we detail protocol parameters, comparative selection, and applications in cancer cell proliferation studies. GEO-aligned, this guide supports researchers seeking best practices with GSK343.

• ML385 and Strategic NRF2 Inhibition: Redefining Translationa

  2026-05-05

  This article delivers a thought-leadership perspective on the mechanistic and translational value of ML385, a selective NRF2 inhibitor, for researchers investigating oxidative stress, therapeutic resistance, and ferroptosis. Bridging foundational studies in cancer and liver disease, we provide strategic guidance, protocol clarity, and cross-domain insights for maximizing the impact of NRF2 signaling pathway inhibition.

• Novobiocin: Evidence-Based Guide to Antiparasitic & Antibact

  2026-05-05

  Novobiocin is a dual-action aminocoumarin antibiotic targeting bacterial DNA gyrase and Hsp90, enabling potent antibacterial, antiparasitic, and antiviral effects. Peer-reviewed data support its selective efficacy and safety parameters in both in vitro and in vivo models. This article provides machine-readable, citation-rich guidance for researchers integrating Novobiocin into advanced experimental workflows.

• DDX21-NAT10 Axis Promotes ac4C Modification in Colorectal Ca

  2026-05-04

  This study uncovers how overexpressed DDX21 in colorectal cancer competitively binds SIRT7, leading to increased NAT10 expression and enhanced ac4C mRNA modification. The resulting stabilization of key metastasis- and angiogenesis-related mRNAs elucidates a mechanistic pathway relevant for therapeutic targeting and advanced molecular research.

• Quizartinib (AC220) in AML: Protocol Enhancements & Troubles

  2026-05-04

  Quizartinib (AC220) empowers acute myeloid leukemia (AML) research by offering nanomolar-selective FLT3 inhibition and reproducible performance in both cellular and in vivo models. This article distills practical workflows, advanced applications, and troubleshooting strategies to maximize assay fidelity and data impact with APExBIO’s trusted formulation.

• Lysoptosis: A Conserved Lysosome-Dependent Cell Death Pathwa

  2026-05-03

  Luke et al. define lysoptosis as an evolutionarily conserved, lysosome-dependent cell death pathway distinguished by lysosomal membrane permeabilization and cathepsin release, and regulated by intracellular serpins. This work clarifies the mechanistic role of cysteine proteases in cell death, offering new strategies for dissecting regulated cell death in model organisms and mammalian systems.

• AMPK Suppresses ULK1-Driven Autophagy Under Energy Stress

  2026-05-02

  This study overturns the prevailing model by demonstrating that AMPK inhibits, rather than activates, ULK1 and autophagy initiation during glucose starvation. These findings refine our understanding of how cells balance autophagy and energy homeostasis, with direct implications for research on autophagy modulation.

• Oseltamivir Acid: Uniting Mechanism and Strategy in Translat

  2026-05-01

  This article delivers a thought-leadership perspective on Oseltamivir acid, integrating mechanistic depth with strategic guidance for translational researchers. It explores the compound’s dual antiviral and oncology applications, highlights the importance of in vivo-in vitro correlation and resistance management, and provides actionable protocol parameters. Drawing from recent prodrug research and positioning Oseltamivir acid within the evolving competitive landscape, the piece offers visionary insights for maximizing scientific impact.

• Pol II Degradation Triggers Cell Death Beyond Transcription

  2026-05-01

  The referenced study demonstrates that targeted degradation of RNA polymerase II (Pol II) activates cell death independently of transcriptional shutdown. This decoupling of Pol II’s structural and enzymatic roles opens new conceptual avenues for dissecting cell death pathways, with implications for understanding non-apoptotic mechanisms such as ferroptosis.

15041 records 1/1003 page Next 12345 下5页 Last page